Get the Stockscreener App
2.705
3.76%
-0.1057
After Hours:
2.71
0.005
+0.18%
Reshape Lifesciences Inc Stock (RSLS) Latest News
Key Trend Revolutionizing the Bariatric Surgery Devices Market in 2025: Olympus Fully Launches Next-Level S... - WhaTech
Synthetic Biosensors Market: Trends, Applications & Growth - openPR
AI and Automation reshape revenue management in the Life Sciences industry - ETHealthWorld
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
ReShape Lifesciences receives international patent in Israel for its proprietary diabetes neuromodulation technology; shares rise - MSN
ReShape Lifesciences secures key diabetes treatment patent - MSN
ReShape Lifesciences® Granted Key International Patent in - GlobeNewswire
Groundbreaking Diabetes Tech Patent Win: ReShape's Neural Solution Could Eliminate Daily Medications - StockTitan
Bariatric Surgery Market to Surpass USD 3.34 Billion by 2032, Growing at a CAGR of 7.85% - EIN News
Electroceutical Devices Market Projected To Witness Massive Growth, 2025-2032 | Medtronic plc, Abbott Laboratories - openPR
Bariatric Surgery Devices Market: Robust Growth, Key Players, and Future Trends - openPR
RSLS Stock Touches 52-Week Low at $4.07 Amid Market Challenges By Investing.com - Investing.com South Africa
RSLS Stock Touches 52-Week Low at $4.07 Amid Market Challenges - Investing.com India
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, OMIC, NEUE, RSLS on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerRSLS, TURN, RDW, NEUE - Markets Insider
ReShape Lifesciences amends convertible note terms with investor By Investing.com - Investing.com Australia
ReShape Lifesciences amends convertible note terms with investor - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GLXZ, R - GuruFocus.com
ReShape Lifesciences updates on merger with Vyome Therapeutics - TipRanks
ReShape and Vyome to merge in all-stock deal By Investing.com - Investing.com Australia
ReShape and Vyome to merge in all-stock deal - Investing.com
ReShape Lifesciences® Provides Update on Merger Agreement - GlobeNewswire
ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys - Yahoo Finance
Obesity Treatment Market is Booming Worldwide | Pfizer, Nutrisystem, Roche, - openPR
Rising Burden of Neurological Disorders in Emerging Economies Fuels Demand for Vagus Nerve Stimulation Therapy - PharmiWeb.com
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Global Bariatric Surgery Devices Market Set For 9.3% Growth, Reaching $2.98 Billion By 2028 - NEWS CHANNEL NEBRASKA
Synthetic Biosensors Market Set to Witness Steady Growth through (2024-2031) - WhaTech
RSLS Stock Touches 52-Week Low at $4.48 Amid Market Challenges By Investing.com - Investing.com South Africa
ReShape Lifesciences Announces Merger and Asset Sale Plans - TipRanks
RSLS Stock Touches 52-Week Low at $4.48 Amid Market Challenges - Investing.com
Bariatric Surgery Devices Market is expected to grow at a CAGR - openPR
ReShape Lifesciences faces Nasdaq delisting over equity shortfall - Investing.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, RS - GuruFocus.com
Bariatric Surgery Devices Market Global Forecasts Report and Company Analysis 2025-2033, Featuring Apollo Endosurgery, GI Dynamics, Intuitive Surgical, J&J, Medtronic, Olympus, Reshape, TransEnterix - GlobeNewswire
Weight-Loss Devices Market Will Drive an Exponential CAGR - openPR
Intragastric Balloons Market Size to Surpass USD 160.7 - GlobeNewswire
Earnings call: ReShape Lifesciences reports growth and strategic mergers - Investing.com
Earnings call: ReShape Lifesciences reports growth and strategic mergers By Investing.com - Investing.com Canada
ReShape Lifesciences Inc (RSLS) Quarterly 10-Q Report - Quartzy
ReShape Lifesciences Reports Q3 Growth and Strategic Moves - TipRanks
ReShape Lifesciences® Reports Third Quarter Ended September - GlobeNewswire
ReShape Lifesciences Reports 16.6% Revenue Growth, Inks $5.16M Asset Sale Deal | RSLS Stock News - StockTitan
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update - The Manila Times
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and - The Bakersfield Californian
Gastric Electrical Stimulators Market Size, Share and Growth - openPR
Health Canada approves ReShape's Lap-Band 2.0 FLEX By Investing.com - Investing.com Australia
FibroGen Reports Third Quarter 2024 Financial Results - The Manila Times
ReShape Lifesciences® to Announce Financial Results for the - GlobeNewswire
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - The Manila Times
ReShape Lifesciences (RSLS) Sets Q3 2024 Earnings Call with Post-Merger Chairman | RSLS Stock News - StockTitan
ReShape secures NIH grant to develop electrodes for diabetes treatment device - Medical Device Network
Health Canada approves ReShape's Lap-Band 2.0 FLEX - Investing.com
0.38%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):